15-69455181-C-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000260379.11(RPLP1):c.159C>A(p.Asn53Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000251 in 1,592,240 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N53S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000260379.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPLP1 | NM_001003.3 | c.159C>A | p.Asn53Lys | missense_variant | 3/4 | ENST00000260379.11 | NP_000994.1 | |
RPLP1 | NM_213725.2 | c.84C>A | p.Asn28Lys | missense_variant | 2/3 | NP_998890.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPLP1 | ENST00000260379.11 | c.159C>A | p.Asn53Lys | missense_variant | 3/4 | 1 | NM_001003.3 | ENSP00000346037.5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000853 AC: 2AN: 234552Hom.: 0 AF XY: 0.00000788 AC XY: 1AN XY: 126968
GnomAD4 exome AF: 0.00000208 AC: 3AN: 1440016Hom.: 0 Cov.: 30 AF XY: 0.00000140 AC XY: 1AN XY: 715392
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152224Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.159C>A (p.N53K) alteration is located in exon 3 (coding exon 3) of the RPLP1 gene. This alteration results from a C to A substitution at nucleotide position 159, causing the asparagine (N) at amino acid position 53 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at